Literature DB >> 22661495

Bacterial infections in end-stage liver disease: current challenges and future directions.

Jasmohan S Bajaj1, Jacqueline G O'Leary, Florence Wong, K Rajender Reddy, Patrick S Kamath.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22661495      PMCID： PMC3604694          DOI： 10.1136/gutjnl-2012-302339

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  76 in total

1.  Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.

Authors:  P Angeli; S Guarda; S Fasolato; E Miola; R Craighero; F Piccolo; C Antona; L Brollo; M Franchin; U Cillo; C Merkel; A Gatta
Journal:  Aliment Pharmacol Ther       Date:  2006-01-01       Impact factor: 8.171

2.  The economic impact of infection control: making the business case for increased infection control resources.

Authors:  Patricia W Stone; Edwin C Hedblom; Denise M Murphy; Steven B Miller
Journal:  Am J Infect Control       Date:  2005-11       Impact factor: 2.918

3.  One year outcome of intensive care patients with decompensated alcoholic liver disease.

Authors:  I J Mackle; D G Swann; B Cook
Journal:  Br J Anaesth       Date:  2006-07-18       Impact factor: 9.166

4.  Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.

Authors:  Carlos Terra; Mónica Guevara; Aldo Torre; Rosa Gilabert; Javier Fernández; Marta Martín-Llahí; Maria E Baccaro; Miquel Navasa; Conxita Bru; Vicente Arroyo; Juan Rodés; Pere Ginès
Journal:  Gastroenterology       Date:  2005-12       Impact factor: 22.682

5.  Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis.

Authors:  M Deschênes; J P Villeneuve
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

6.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

7.  Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features.

Authors:  Silvano Fasolato; Paolo Angeli; Lucia Dallagnese; Giulio Maresio; Erika Zola; Elena Mazza; Freddy Salinas; Silvio Donà; Stefano Fagiuoli; Antonietta Sticca; Giacomo Zanus; Umberto Cillo; Ilaria Frasson; Carla Destro; Angelo Gatta
Journal:  Hepatology       Date:  2007-01       Impact factor: 17.425

Review 8.  Bacterial infections, sepsis, and multiorgan failure in cirrhosis.

Authors:  Puneeta Tandon; Guadalupe Garcia-Tsao
Journal:  Semin Liver Dis       Date:  2008-02       Impact factor: 6.115

9.  Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.

Authors:  Rubén Francés; Pedro Zapater; José M González-Navajas; Carlos Muñoz; Rocío Caño; Rocío Moreu; Sonia Pascual; Pablo Bellot; Miguel Pérez-Mateo; José Such
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more
  26 in total

1.  Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis.

Authors:  Jasmohan S Bajaj; Jacqueline G OʼLeary; Puneeta Tandon; Florence Wong; Guadalupe Garcia-Tsao; Patrick S Kamath; Scott W Biggins; Jennifer C Lai; Hugo E Vargas; Benedict Maliakkal; Michael B Fallon; Paul J Thuluvath; Ram M Subramanian; Leroy R Thacker; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

Review 2.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

3.  Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

Authors:  Jasmohan S Bajaj; Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Scott W Biggins; Heather Patton; Michael B Fallon; Guadalupe Garcia-Tsao; Benedict Maliakkal; Raza Malik; Ram M Subramanian; Leroy R Thacker; Patrick S Kamath
Journal:  Hepatology       Date:  2014-05-29       Impact factor: 17.425

4.  The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.

Authors:  Jasmohan S Bajaj; K Rajender Reddy; Puneeta Tandon; Florence Wong; Patrick S Kamath; Guadalupe Garcia-Tsao; Benedict Maliakkal; Scott W Biggins; Paul J Thuluvath; Michael B Fallon; Ram M Subramanian; Hugo Vargas; Leroy R Thacker; Jacqueline G O'Leary
Journal:  Hepatology       Date:  2016-02-19       Impact factor: 17.425

5.  Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.

Authors:  Jacqueline G O'Leary; K Rajender Reddy; Florence Wong; Patrick S Kamath; Heather M Patton; Scott W Biggins; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-12       Impact factor: 11.382

Review 6.  Influence of cirrhosis in cardiac surgery outcomes.

Authors:  Juan C Lopez-Delgado; Francisco Esteve; Casimiro Javierre; Josep L Ventura; Rafael Mañez; Elisabet Farrero; Herminia Torrado; David Rodríguez-Castro; Maria L Carrio
Journal:  World J Hepatol       Date:  2015-04-18

7.  Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell.

Authors:  Haiyan Wang; Xuehui Li; Guanjun Dong; Fenglian Yan; Junfeng Zhang; Hui Shi; Zhaochen Ning; Min Gao; Dalei Cheng; Qun Ma; Changying Wang; Mingsheng Zhao; Jun Dai; Chunxia Li; Zhihua Li; Hui Zhang; Huabao Xiong
Journal:  Inflammation       Date:  2020-10-20       Impact factor: 4.092

8.  Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.

Authors:  Alexandra Alexopoulou; Larisa Vasilieva; Danai Agiasotelli; Kyriaki Siranidi; Sophia Pouriki; Athanasia Tsiriga; Marina Toutouza; Spyridon P Dourakis
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

9.  Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

Authors:  Ranjeeta Bahirwani; Marwan Ghabril; Kimberly A Forde; Hemant Chatrath; Karen M Wolf; Lindsay Uribe; K Rajender Reddy; Barry Fuchs; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 11.382

10.  A multicenter prospective study of infections related morbidity and mortality in cirrhosis of liver.

Authors:  Rajiv Baijal; Deepak Amarapurkar; H R Praveen Kumar; Sandeep Kulkarni; Nimish Shah; Soham Doshi; Deepak Gupta; Mayank Jain; Nikhil Patel; Praful Kamani; S K Issar; Mrudul Dharod; Apoorva Shah; Madhuri Chandnani; Sonali Gautam
Journal:  Indian J Gastroenterol       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.